Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study

Hoyun Kim1, Do-Yoon Kang1, Jung-Min Ahn1

  • 1Heart Institute, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

PubMed

Insights

For patients with multivessel coronary artery disease, coronary artery bypass grafting (CABG) shows better outcomes than percutaneous coronary intervention (PCI) in diabetics. Mortality rates were similar between CABG and PCI regardless of diabetes status.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Diabetes Mellitus Research

Background:

  • Diabetes mellitus is linked to more complex coronary artery disease.
  • Coronary artery bypass grafting (CABG) is often preferred over percutaneous coronary intervention (PCI) for diabetics with multivessel coronary artery disease (MVD).

Purpose of the Study:

  • To evaluate the prognostic impact of revascularization strategies (PCI vs. CABG) based on diabetes status.
  • To analyze outcomes from the BEST trial, comparing PCI with everolimus-eluting stents to CABG in MVD patients.

Main Methods:

  • 880 patients with MVD were randomized to PCI or CABG.
  • Patients were stratified into diabetic (n=363) and nondiabetic (n=517) groups.
  • The primary endpoint was a composite of death, myocardial infarction, or target vessel revascularization over an 11.8-year median follow-up.

Main Results:

  • Diabetic patients had a significantly higher primary endpoint rate with PCI versus CABG (43% vs. 32%).
  • No significant difference in the primary endpoint was observed between PCI and CABG in nondiabetic patients (29% vs. 29%).
  • Repeat revascularization rates were higher with PCI compared to CABG, irrespective of diabetes status.

Conclusions:

  • CABG demonstrated superior clinical outcomes compared to PCI in diabetic patients with MVD.
  • Mortality rates were comparable between PCI and CABG across both diabetic and nondiabetic groups during extended follow-up.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11